They believe a drug used by transplant patients could also have an impact on the health and longevity of man's best friend.
Matthew Kaeberline and Daniel Promislow received an unrestricted $200,000 grant from the UW to study Rapamycin's potential effects on the longevity of dogs.
More
1 comment:
Everybody fusses about "GMO" and "Organic" (Baseless and over manipulated) blah blah blah, but making Frankenpets is OK? #idiotlogic
Post a Comment